Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
2.150
+0.110 (5.39%)
Nov 20, 2024, 4:00 PM EST - Market closed

Envoy Medical Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Envoy Medical stock have an average target of 7.92, with a low estimate of 6.00 and a high estimate of 9.00. The average target predicts an increase of 268.37% from the current stock price of 2.15.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $6.00 $7.92 $8.75 $9.00
Change +179.07% +268.37% +306.98% +318.60%
* Price targets were last updated on Oct 14, 2024.

Analyst Ratings

The average analyst rating for Envoy Medical stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 222233
Buy 111111
Hold 000000
Sell 000000
Strong Sell 000000
Total 333344

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Brookline Capital
Brookline Capital
Strong Buy
Initiates
$9
Strong Buy Initiates $9 +318.60% Oct 14, 2024
Ascendiant Capital
Ascendiant Capital
Strong Buy
Maintains
$8.5$8.75
Strong Buy Maintains $8.5$8.75 +306.98% Sep 3, 2024
Ascendiant Capital
Ascendiant Capital
Strong Buy
Initiates
$8.5
Strong Buy Initiates $8.5 +295.35% Jun 24, 2024
Lake Street
Lake Street
Strong Buy
Maintains
$3$6
Strong Buy Maintains $3$6 +179.07% Apr 3, 2024
Northland Capital Markets
Northland Capital Markets
Buy
Initiates
n/a
Buy Initiates n/a n/a Dec 21, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
290.36K
from 316.00K
Decreased by -8.11%
Revenue Next Year
340.00K
from 290.36K
Increased by 17.09%
EPS This Year
-1.10
from -2.38
EPS Next Year
-1.14
from -1.10
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
310.00K237.00K316.00K290.36K340.00K652.80K
Revenue Growth
--23.55%33.33%-8.11%17.09%92.00%
EPS
-0.86-1.57-2.38-1.10-1.14-0.57
EPS Growth
------
Forward PE
------
No. Analysts ---663
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High 315,000 420,000 672,000
Avg 290,363 339,997 652,800
Low 271,460 294,000 627,200

Revenue Growth

Revenue Growth 202420252026
High
-0.3%
44.6%
97.6%
Avg
-8.1%
17.1%
92.0%
Low
-14.1%
1.3%
84.5%

EPS Forecast

EPS 202420252026
High -1.12 -1.10 -0.59
Avg -1.10 -1.14 -0.57
Low -1.06 -1.14 -0.55

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.